We are live on ! Find out more
DAM

DLD Asset Management Portfolio holdings

AUM $1.51B
1-Year Est. Return 5.32%
This Fund
S&P 500
This Quarter Est. Return
+1.05%
1 Year Est. Return
+5.32%
3 Year Est. Return
+10.27%
5 Year Est. Return
+32.59%
10 Year Est. Return
AUM
$305M
AUM Growth
Cap. Flow
+$21.5M
Cap. Flow %
7.03%
Top 10 Hldgs %
78.06%
Holding
71
New
62
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Miscellaneous 92.68%
2 Healthcare 2.07%
3 Financials 1.35%
4 Communication Services 1.19%
5 Materials 0.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRTX icon
1
CALL
Vertex Pharmaceuticals
VRTX
$137B
$15.7M 5.13%
+212,600
New +$17.3M
VRTX icon
2
PUT
Vertex Pharmaceuticals
VRTX
$137B
$13.6M 4.46%
+184,700
New +$15M
BCRX icon
3
CALL
BioCryst Pharmaceuticals
BCRX
$2.51B
$7.97M 2.61%
+1,258,700
New +$6.55M
HZNP
4
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$7.23M 2.37%
+446,900
New +$8.1M
ALR
5
CALL
DELISTED
Alere Inc
ALR
$5.85M 1.92%
+150,100
New +$6.07M
ACOR
6
PUT
DELISTED
Acorda Therapeutics
ACOR
$4.66M 1.52%
+2,061
New +$4.9M
VGR
7
PUT
DELISTED
Vector Group Ltd.
VGR
$4.5M 1.47%
+322,859
New +$4.19M
GNMX
8
CALL
DELISTED
Aevi Genomic Medicine Inc
GNMX
$2.88M 0.94%
+555,000
New +$2.92M
CHTR icon
9
Charter Communications
CHTR
$18.3B
$2.85M 0.93%
+9,905
New +$2.67M
RAD
10
PUT
DELISTED
Rite Aid Corporation
RAD
$2.67M 0.87%
+16,200
New +$2.45M
ACOR
11
DELISTED
Acorda Therapeutics
ACOR
$2.55M 0.83%
+1,129
New +$2.68M
ANIP icon
12
PUT
ANI Pharmaceuticals
ANIP
$1.67B
$2.48M 0.81%
+41,000
New +$2.51M
RCKT icon
13
CALL
Rocket Pharmaceuticals
RCKT
$424M
$2.12M 0.7%
+86,800
New +$2.48M
LCI
14
PUT
DELISTED
Lannett Company, Inc.
LCI
$1.43M 0.47%
+16,250
New +$1.5M
RAD
15
DELISTED
Rite Aid Corporation
RAD
$1.31M 0.43%
+7,956
New +$1.2M
ZGNX
16
CALL
DELISTED
Zogenix, Inc.
ZGNX
$1.27M 0.42%
+104,400
New +$1.15M
AEPI
17
DELISTED
AEP Industries Inc
AEPI
$1.16M 0.38%
+10,000
New +$1.13M
STJ
18
DELISTED
St Jude Medical
STJ
$962K 0.32%
+12,000
New +$952K
RAI
19
DELISTED
Reynolds American Inc
RAI
$841K 0.28%
+15,000
New +$796K
HZNP
20
PUT
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$809K 0.26%
+50,000
New +$907K
PRTK
21
PUT
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$708K 0.23%
+46,000
New +$597K
RCKT icon
22
PUT
Rocket Pharmaceuticals
RCKT
$424M
$695K 0.23%
+28,375
New +$810K
YDKN
23
DELISTED
Yadkin Financial Corporation
YDKN
$685K 0.22%
+20,000
New +$608K
BATS
24
DELISTED
Bats Global Markets, Inc.
BATS
$670K 0.22%
+20,000
New +$628K
PVTB
25
DELISTED
PrivateBancorp Inc
PVTB
$650K 0.21%
+12,000
New +$578K

Similar funds

DLD Asset Management's Q4 2016 Portfolio in Review

Q4 2016 is the first quarter with a 13F filing on record for DLD Asset Management, which disclosed 71 positions worth $305M. Its ten largest holdings account for 78% of the portfolio.

Its largest position is Acorda Therapeutics: 1,129 shares worth $2.55M.

By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, followed by Healthcare and Financials.

  • DLD Asset Management's largest Q4 2016 buy was Acorda Therapeutics: 1,129 shares worth $2.55M.
  • DLD Asset Management's ten largest holdings make up 78% of its $305M portfolio in Q4 2016.
  • DLD Asset Management disclosed 71 positions in Q4 2016, its first 13F filing on record.

Based on DLD Asset Management's 13F filing for Q4 2016, filed 13 Feb 2017.